A Bidens pilosa L. Non-Polar Extract Modulates the Polarization of Human Macrophages and Dendritic Cells into an Anti-Inflammatory Phenotype

Molecules. 2023 Oct 14;28(20):7094. doi: 10.3390/molecules28207094.

Abstract

Different communities around the world traditionally use Bidens pilosa L. for medicinal purposes, mainly for its anti-inflammatory, antinociceptive, and antioxidant properties; it is used as an ingredient in teas or herbal medicines for the treatment of pain, inflammation, and immunological disorders. Several studies have been conducted that prove the immunomodulatory properties of this plant; however, it is not known whether the immunomodulatory properties of B. pilosa are mediated by its ability to modulate antigen-presenting cells (APCs) such as macrophages (MØs) and dendritic cells (DCs) (through polarization or the maturation state, respectively). Different polar and non-polar extracts and fractions were prepared from the aerial part of B. pilosa. Their cytotoxic and immunomodulatory effects were first tested on human peripheral blood mononuclear cells (PBMCs) and phytohemagglutinin (PHA)-stimulated PBMCs, respectively, via an MTT assay. Then, the non-cytotoxic plant extracts and fractions that showed the highest immunomodulatory activity were selected to evaluate their effects on human MØ polarization and DC maturation (cell surface phenotype and cytokine secretion) through multiparametric flow cytometry. Finally, the chemical compounds of the B. pilosa extract that showed the most significant immunomodulatory effects on human APCs were identified using gas chromatography coupled with mass spectrometry. The petroleum ether extract and the ethyl acetate and hydroalcoholic fractions obtained from B. pilosa showed low cytotoxicity and modulated the PHA-stimulated proliferation of PBMCs. Furthermore, the B. pilosa petroleum ether extract induced M2 polarization or a hybrid M1/M2 phenotype in MØs and a semi-mature status in DCs, regardless of exposure to a maturation stimulus. The immunomodulatory activity of the non-polar (petroleum ether) extract of B. pilosa on human PBMC proliferation, M2 polarization of MØs, and semi-mature status in DCs might be attributed to the low-medium polarity components in the extract, such as phytosterol terpenes and fatty acid esters.

Keywords: Bidens pilosa L.; dendritic cells; immunomodulation; macrophages; phytochemistry; phytotherapy; traditional medicine.

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Bidens*
  • Dendritic Cells
  • Gas Chromatography-Mass Spectrometry
  • Humans
  • Leukocytes, Mononuclear
  • Macrophages
  • Phenotype
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology
  • Solvents

Substances

  • naphtha
  • Plant Extracts
  • Anti-Inflammatory Agents
  • Solvents

Grants and funding

This work was funded by the Pontificia Universidad Javeriana; the Ministry of Science, Technology and Innovation; the Ministry of National Education; the Ministry of Industry, Commerce and Tourism; and ICETEX. Second Call of the Scientific Ecosystem, Colombia Científica, 792-2017. Program “Generation of alternatives therapeutics in cancer from plants through translational research and development processes, articulated in environmentally and economically sustainable valuable systems” (Contract No. FP44842-221-2018) and the Juan N. Corpas University Foundation.